Abnormalities of the ARF-p53 pathway in oral squamous cell carcinoma

被引:39
作者
Bradley, G
Irish, J
MacMillan, C
Mancer, K
Witterick, I
Hartwick, W
Gullane, P
Kamel-Reid, S
Benchimol, S
机构
[1] Univ Toronto, Fac Dent, Toronto, ON M5G 1G6, Canada
[2] Univ Toronto, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada
[3] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada
[4] Univ Toronto, Princess Margaret Hosp, Dept Otolaryngol Surg Oncol, Toronto, ON M5G 2M9, Canada
[5] Univ Toronto, Toronto Gen Hosp, Dept Pathol, Toronto, ON M5G 2C4, Canada
[6] Univ Toronto, Mt Sinai Hosp, Dept Otolaryngol, Toronto, ON M5G 1X5, Canada
[7] Univ Toronto, Mt Sinai Hosp, Dept Pathol, Toronto, ON M5G 1X5, Canada
基金
英国医学研究理事会;
关键词
p53; mutation; immunohistochemistry; p14ARF; homozygous deletion; oral squamous carcinoma;
D O I
10.1038/sj.onc.1204131
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Oral squamous cell carcinoma (OSCC) is associated with heavy smoking and drinking, but the molecular pathway of tumorigenesis is not understood. Inactivation of the p53 tumor suppressor gene is likely to play an important role since p53 mutation is frequently found. The p14ARF tumor suppressor gene is functionally linked to p53, because it is activated by oncogenes and causes p53-dependent growth arrest and apoptosis, The relationship between p14ARF and p53 inactivation has not been described for OSCC, We studied 25 cases of OSCC to determine if there is an inverse correlation between p53 mutation and p14ARF inactivation by homozygous deletion or mutation. p53 mutation was found in 16 of 25 cases (64%), including nine missense and seven truncating mutations, While all cases with missense mutations showed abnormal accumulation of p53 protein, there were also five carcinomas which showed increased p53 staining in the absence of mutation. p14ARF deletion or mutation was found in eight cases (32%), six of which also demonstrated p53 mutation. Our findings indicate that OSCC often involves loss of both p14ARF and p53 function and suggest that inactivation of these two tumor suppressor genes are not functionally equivalent during tumorigenesis.
引用
收藏
页码:654 / 658
页数:5
相关论文
共 30 条
[21]  
2-L
[22]  
Prives C, 1999, J PATHOL, V187, P112
[23]   The p16INK4a/CDKN2A tumor suppressor and its relatives [J].
Ruas, M ;
Peters, G .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1998, 1378 (02) :F115-F177
[24]   Inactivation of the INK4A/ARF locus frequently coexists with TP53 mutations in non-small cell lung cancer [J].
Sanchez-Cespedes, M ;
Reed, AL ;
Buta, M ;
Wu, L ;
Westra, WH ;
Herman, JG ;
Yang, SC ;
Jen, J ;
Sidransky, D .
ONCOGENE, 1999, 18 (43) :5843-5849
[25]  
Shahnavaz SA, 2000, J PATHOL, V190, P417
[26]   The ARF/p53 pathway [J].
Sherr, CJ ;
Weber, JD .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2000, 10 (01) :94-99
[27]   Tumor surveillance via the ARF-p53 pathway [J].
Sherr, CJ .
GENES & DEVELOPMENT, 1998, 12 (19) :2984-2991
[28]   The alternative product from the human CDKN2A locus, p14ARF, participates in a regulatory feedback loop with p53 and MDM2 [J].
Stott, FJ ;
Bates, S ;
James, MC ;
McConnell, BB ;
Starborg, M ;
Brookes, S ;
Palmero, I ;
Ryan, K ;
Hara, E ;
Vousden, KH ;
Peters, G .
EMBO JOURNAL, 1998, 17 (17) :5001-5014
[29]   OVEREXPRESSION OF P53 PROTEIN IN SQUAMOUS-CELL CARCINOMAS OF HEAD AND NECK WITHOUT APPARENT GENE-MUTATIONS [J].
XU, L ;
CHEN, YT ;
HUVOS, AG ;
ZLOTOLOW, IM ;
RETTIG, WJ ;
OLD, LJ ;
GARINCHESA, P .
DIAGNOSTIC MOLECULAR PATHOLOGY, 1994, 3 (02) :83-92
[30]   Mutations in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53 [J].
Zhang, YP ;
Xiong, Y .
MOLECULAR CELL, 1999, 3 (05) :579-591